| Indicators | Browse All

biote Corp. (BTMD)

Healthcare | Medical Care Facilities | Irving, United States | NasdaqGM
2.32 USD -0.01 (-0.429%) ⇩ (July 13, 2026, 4 p.m. EDT)

Short-term:★★☆☆☆Long-term:★⯪☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 2:53 a.m. EDT

The immediate outlook is bearish due to a sharp technical breakdown; the stock has lost nearly 25% over the last two weeks, trading well below its 50-day moving average, which suggests continued downward pressure in the near term. However, the long-term investment case is severely compromised by deteriorating fundamentals and a multi-year price collapse. Despite a low P/E ratio, the company is generating negative free cash flow, reporting significant revenue declines, and has suffered a nearly 58% drop in value over the past four years. The recent news of dropping off major indices and interim CEO compensation packages further highlights the instability and lack of institutional confidence, making this a weak hold rather than a buy.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.067893
MSTL0.080578
AutoTheta0.092238
AutoARIMA0.259674

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 35%
H-stat 2.31
Ljung-Box p 0.000
Jarque-Bera p 0.191
Excess Kurtosis 0.59
Attribute Value
Sector Healthcare
Revenue per Share 6.055
Market Cap 82,483,144
Trailing P/E 5.40
Forward P/E 4.07
Beta 1.66
Profit Margins 8.29%
Website https://www.biote.com

Info Dump

Attribute Value
52 Week Change -0.4232673
Address1 1,875 W. Walnut Hill Ln #100
All Time High 10.525
All Time Low 1.27
Ask 2.9
Ask Size 2
Audit Risk 10
Average Daily Volume10 Day 592,770
Average Daily Volume3 Month 279,040
Average Volume 279,040
Average Volume10Days 592,770
Beta 1.661
Bid 1.7
Bid Size 2
Board Risk 8
Book Value -1.871
City Irving
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 9
Country United States
Crypto Tradeable 0
Currency USD
Current Price 2.32
Current Ratio 1.288
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 2.4
Day Low 2.26
Display Name biote
Earnings Call Timestamp End 1,778,101,200
Earnings Call Timestamp Start 1,778,101,200
Earnings Growth -0.838
Earnings Quarterly Growth -0.834
Earnings Timestamp 1,778,097,600
Earnings Timestamp End 1,785,960,000
Earnings Timestamp Start 1,785,960,000
Ebitda 32,858,000
Ebitda Margins 0.17462999
Enterprise To Ebitda 5.527
Enterprise To Revenue 0.965
Enterprise Value 181,606,912
Eps Current Year 0.47
Eps Forward 0.57
Eps Trailing Twelve Months 0.43
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 2.1381
Fifty Day Average Change 0.18190002
Fifty Day Average Change Percent 0.08507555
Fifty Two Week Change Percent -42.32673
Fifty Two Week High 4.75
Fifty Two Week High Change -2.43
Fifty Two Week High Change Percent -0.511579
Fifty Two Week Low 1.27
Fifty Two Week Low Change 1.05
Fifty Two Week Low Change Percent 0.8267716
Fifty Two Week Range 1.27 - 4.75
Financial Currency USD
First Trade Date Milliseconds 1,619,616,600,000
Float Shares 19,627,162
Forward Eps 0.57
Forward P E 4.070175
Free Cashflow -4,732,875
Full Exchange Name NasdaqGM
Full Time Employees 223
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,782,864,000
Gross Margins 0.70115995
Gross Profits 131,932,000
Has Pre Post Market Data 1
Held Percent Insiders 0.103879996
Held Percent Institutions 0.6738
Implied Shares Outstanding 35,553,078
Industry Medical Care Facilities
Industry Disp Medical Care Facilities
Industry Key medical-care-facilities
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.
Long Name biote Corp.
Market us_market
Market Cap 82,483,144
Market State PRE
Max Age 86,400
Message Board Id finmb_1761348473
Most Recent Quarter 1,774,915,200
Net Income To Common 15,604,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 70,672,220
Number Of Analyst Opinions 5
Open 2.345
Operating Cashflow 32,629,000
Operating Margins 0.09781
Overall Risk 9
Payout Ratio 0.0
Phone 844 604 1246
Previous Close 2.33
Price Eps Current Year 4.93617
Price Hint 4
Price To Book -1.2399786
Price To Sales Trailing12 Months 0.4383624
Profit Margins 0.08293
Quick Ratio 0.451
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.00999999
Regular Market Change Percent -0.429184
Regular Market Day High 2.4
Regular Market Day Low 2.26
Regular Market Day Range 2.26 - 2.4
Regular Market Open 2.345
Regular Market Previous Close 2.33
Regular Market Price 2.32
Regular Market Time 1,783,972,800
Regular Market Volume 185,606
Return On Assets 0.17809999
Revenue Growth -0.083
Revenue Per Share 6.055
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 6
Shares Outstanding 30,331,425
Shares Percent Shares Out 0.0183
Shares Short 553,643
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 1,412,998
Short Name Biote Corp.
Short Percent Of Float 0.0252
Short Ratio 1.35
Source Interval 15
State TX
Symbol BTMD
Target High Price 4.0
Target Low Price 2.0
Target Mean Price 2.986
Target Median Price 3.0
Total Cash 5,320,000
Total Cash Per Share 0.175
Total Debt 108,422,000
Total Revenue 188,162,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 0.43
Trailing P E 5.3953485
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 2.294425
Two Hundred Day Average Change 0.025574923
Two Hundred Day Average Change Percent 0.01114655
Type Disp Equity
Volume 185,606
Website https://www.biote.com
Zip 75,038